{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:23:04Z","timestamp":1790799784977,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.suc.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T18:39:08Z","timestamp":1572633548000},"page":"127-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Role of Surgery for Metastatic Melanoma"],"prefix":"10.1016","volume":"100","author":[{"given":"Laura M.","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Votanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2019.09.011_bib1","unstructured":"Key Statistics for Melanoma Skin Cancer, American Cancer Society. Available at: https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html#references. Accessed March 19, 2019."},{"issue":"9","key":"10.1016\/j.suc.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archsurg.139.9.961","article-title":"Contemporary surgical treatment of advanced-stage melanoma","volume":"139","author":"Essner","year":"2004","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.suc.2019.09.011_bib3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1245\/s10434-012-2398-z","article-title":"Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)","volume":"19","author":"Howard","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.suc.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.suc.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-term survival after complete surgical resection and adjuvant immunotherapy for distant melanoma metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.suc.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1002\/cncr.26111","article-title":"A\u00a0phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430","volume":"117","author":"Sosman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2019.09.011_bib8","series-title":"Melanoma: A Modern Multidisciplinary Approach","first-page":"467","article-title":"Surgery for Stage IV Metastatic Melanoma","author":"Ollila","year":"2018"},{"issue":"2","key":"10.1016\/j.suc.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0b013e31824bc981","article-title":"Surgery for distant melanoma metastasis","volume":"18","author":"Leung","year":"2012","journal-title":"Cancer J"},{"issue":"450","key":"10.1016\/j.suc.2019.09.011_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.suc.2019.09.011_bib11","first-page":"67","article-title":"Suppressive immunoregulatory factors produced by tumors","volume":"2","author":"Roth","year":"1983","journal-title":"Lymphokine Res"},{"issue":"2","key":"10.1016\/j.suc.2019.09.011_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02303803","article-title":"Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck","volume":"4","author":"Avradopoulos","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02523659","article-title":"Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?","volume":"7","author":"Hsueh","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199210000-00010","article-title":"Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine","volume":"216","author":"Morton","year":"1992","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib15","first-page":"295","article-title":"Metastasectomy in malignant melanoma","volume":"115","author":"Karakousis","year":"1994","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtcvs.2006.08.065","article-title":"Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma","volume":"133","author":"Petersen","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.suc.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/1097-0142(20001101)89:9<1983::AID-CNCR15>3.0.CO;2-S","article-title":"Surgical therapy for distant metastases of malignant melanoma","volume":"89","author":"Meyer","year":"2000","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.suc.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10434-001-0658-4","article-title":"Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?","volume":"8","author":"Wood","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jamcollsurg.2014.04.008","article-title":"A\u00a020-year experience of hepatic resection for melanoma: is there an expanding role?","volume":"219","author":"Faries","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1096-9098(199812)69:4<206::AID-JSO3>3.0.CO;2-N","article-title":"Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma","volume":"69","author":"Ollila","year":"1998","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1998.16.3.1103","article-title":"Prognostic factors for survival of patients treated systemically for disseminated melanoma","volume":"16","author":"Eton","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/bjc.2012.306","article-title":"Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis","volume":"107","author":"Weide","year":"2012","journal-title":"Br J Cancer"},{"issue":"36","key":"10.1016\/j.suc.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2019.09.011_bib24","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.suc.2019.09.011_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/bjc.2017.70","article-title":"Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy","volume":"116","author":"Nosrati","year":"2017","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.suc.2019.09.011_bib26","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S1470-2045(16)30578-2","article-title":"Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials","volume":"17","author":"Long","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.011_bib27","first-page":"449","article-title":"Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma","volume":"63","author":"Kelderman","year":"2014","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejso.2016.11.001","article-title":"Metastasectomy in cutaneous melanoma","volume":"43","author":"Lasithiotakis","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.soc.2014.12.006","article-title":"Metastasectomy for stage IV melanoma","volume":"24","author":"Deutsch","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"issue":"7","key":"10.1016\/j.suc.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ctrv.2008.05.003","article-title":"A\u00a0rational surgical approach to the treatment of distant melanoma metastases","volume":"34","author":"Martinez","year":"2008","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-017-0575-8","article-title":"The role of surgery for melanoma in an era of effective systemic therapy","volume":"19","author":"Raigani","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"16","key":"10.1016\/j.suc.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.suc.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1054\/bjoc.2000.1335","article-title":"Lung metastases from melanoma: when is surgical treatment warranted?","volume":"83","author":"Leo","year":"2000","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.suc.2019.09.011_bib34","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1245\/s10434-007-9448-y","article-title":"Stage-IV melanoma and pulmonary metastases: factors predictive of survival","volume":"14","author":"Neuman","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2019.09.011_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archsurg.2012.1667","article-title":"Preoperative imaging of pulmonary metastases in patients with melanoma: implications for minimally invasive techniques","volume":"147","author":"Kidner","year":"2012","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jso.21961","article-title":"Rationale for complete metastasectomy in patients with stage IV metastatic melanoma","volume":"104","author":"Ollila","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.suc.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archsurg.1996.01430210073013","article-title":"Surgical resection for melanoma metastatic to the gastrointestinal tract","volume":"131","author":"Ollila","year":"1996","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2019.09.011_bib38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00268-001-0027-2","article-title":"Surgery for abdominal metastases of cutaneous melanoma","volume":"25","author":"Gutman","year":"2001","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s10434-999-0336-5","article-title":"Surgery for melanoma metastatic to the gastrointestinal tract","volume":"6","author":"Agrawal","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.011_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archsurg.136.8.950","article-title":"Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience","volume":"136","author":"Rose","year":"2001","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjsurg.2007.12.018","article-title":"Melanoma adrenal metastasis: natural history and surgical management","volume":"195","author":"Mittendorf","year":"2008","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.suc.2019.09.011_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10434-999-0633-z","article-title":"Long-term survival after complete resection of melanoma metastatic to the adrenal gland","volume":"6","author":"Haigh","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.suc.2019.09.011_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/000313481508101019","article-title":"Adrenalectomy for metastatic melanoma: current role in the age of nonsurgical treatments","volume":"81","author":"Flaherty","year":"2015","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(09)70065-8","article-title":"The role of surgery in the management of isolated metastases to the pancreas","volume":"10","author":"Reddy","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(03)00381-8","article-title":"Surgical treatment of splenic metastases in patients with melanoma","volume":"197","author":"de Wilt","year":"2003","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.suc.2019.09.011_bib46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2106\/00004623-197860050-00009","article-title":"Skeletal metastases of melanoma","volume":"60","author":"Stewart","year":"1978","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"3","key":"10.1016\/j.suc.2019.09.011_bib47","first-page":"193","article-title":"Prognostic factors in 1,521 melanoma patients with distant metastases","volume":"181","author":"Barth","year":"1995","journal-title":"J\u00a0Am Coll Surg"},{"issue":"323","key":"10.1016\/j.suc.2019.09.011_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00003086-199602000-00038","article-title":"Heterogeneous survival rates for isolated skeletal metastases from melanoma","author":"DeBoer","year":"1996","journal-title":"Clin Orthop Relat Res"},{"issue":"11","key":"10.1016\/j.suc.2019.09.011_bib49","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(06)70938-X","article-title":"Complete metastasectomy in patients with stage IV metastatic melanoma","volume":"7","author":"Ollila","year":"2006","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.suc.2019.09.011_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.suc.2019.09.011_bib51","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/cncr.25631","article-title":"Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma","volume":"117","author":"Eigentler","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00008390-200010010-00010","article-title":"Melanoma metastatic to the spine: a review of 133 cases","volume":"10","author":"Gokaslan","year":"2000","journal-title":"Melanoma Res"},{"issue":"9486","key":"10.1016\/j.suc.2019.09.011_bib53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-3019(96)00162-0","article-title":"Intramedullary spinal cord metastasis: report of three cases and review of the literature","volume":"46","author":"Connolly","year":"1996","journal-title":"Surg Neurol"},{"issue":"4","key":"10.1016\/j.suc.2019.09.011_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-9098(199908)71:4<209::AID-JSO1>3.0.CO;2-2","article-title":"Metastasectomy for recurrent stage IV melanoma","volume":"71","author":"Ollila","year":"1999","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2019.09.011_bib56","doi-asserted-by":"crossref","first-page":"MMT03","DOI":"10.2217\/mmt-2017-0024","article-title":"Continuing and new roles for surgery in the management of patients with stage IV melanoma","volume":"5","author":"Friedman","year":"2018","journal-title":"Melanoma Manag"},{"issue":"2","key":"10.1016\/j.suc.2019.09.011_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1470-2045(18)30015-9","article-title":"Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial","volume":"19","author":"Amaria","year":"2018","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.suc.2019.09.011_bib58","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat Med"},{"issue":"5 supplement","key":"10.1016\/j.suc.2019.09.011_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2018.36.5_suppl.181","article-title":"Neoadjuvant combination immunotherapy with pembrolizumab and high dose IFN-\u03b12b in locally\/regionally advanced melanoma","volume":"36","author":"Tarhini","year":"2018","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961091930129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961091930129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:10:38Z","timestamp":1758539438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003961091930129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S003961091930129X"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.011","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Surgery for Metastatic Melanoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}